Psoriasis vulgarisli hastalarda sitokin gen polimorfizminin araştırılması

Amaç & Hipotez:Psoriasisde enflamasyondan sorumlu Th hücrelerin ürettikleri proenflamatuvar sitokinler hastalığın patogenezinde önemli yer tutarlar.

📊

Temel Bulgular & Veri:Bu çalışmanın amacı, psoriasis hastalığı ile patogenezde rol alan tümör nekrozu faktörü alfa (TNF-?), interlökin (İL-10), interferon (İFN-?), İL-6, dönüştürücü büyüme faktörü beta (DBF-?) gen polimorfizmleri arasındaki olası ilişkiyi saptamaktır.

💡

Sonuç & Katkı:TT/GC haplotipi hastalarda anlamlı olarak yüksek bulundu (p

🔬Tür:Deneysel Tarla Denemesi

📍Kapsam:89 hasta

⚙️Değişkenler:Alan Parametreleri

Özet

Psoriasisde enflamasyondan sorumlu Th hücrelerin ürettikleri proenflamatuvar sitokinler hastalığın patogenezinde önemli yer tutarlar. Bu çalışmanın amacı, psoriasis hastalığı ile patogenezde rol alan tümör nekrozu faktörü alfa (TNF-?), interlökin (İL-10), interferon (İFN-?), İL-6, dönüştürücü büyüme faktörü beta (DBF-?) gen polimorfizmleri arasındaki olası ilişkiyi saptamaktır. Çalışmaya psoriasis tanısı konmuş 89 hasta ile 201 sağlıklı birey dahil edilmiştir. Hasta grubu, erken başlangıçlı (grup 1) ve geç başlangıçlı (grup 2) olarak ikiye ayrılmıştır. İki grubun sitokin gen polimorfizmleri polimeraz zincir reaksiyonu-sekans spesifik primer yöntemi ile ticari kit kullanılarak tiplenmiştir. Tüm hastalar ile grup 1 hastalarını ayrı ayrı kontrol grubu ile karşılaştırdığımızda DBF-? TT/GC haplotipi hastalarda anlamlı olarak yüksek bulundu (p

Abstract

Psoriasis is associated with cutaneous and systemic overexpression of several proinflammatory cytokines. The aim of this study was to investigate the relationship between susceptibility to psoriasis and polymorphisms of tumor necrosis factor alpha (TNF-?), interferon gamma (INF-?), interleukin (IL-10), IL-6 and transforming growth factor beta (TGF-?). Eighty-nine patients with psoriasis and 201 healthy controls were enrolled into the study. The patient group was divided into 2 subgroups as early-onset (group 1) and late-onset (group 2). The cytokine gene polymorphisms in each group were determined by polymerase chain reaction-single specific primer. When the whole and only group 1 patients were compared with the controls, TGF-? TT/GC genotype was significantly high in the whole and group 1 patients. When we compared the group 1 and group 2, the frequency of IFN-? AA genotype was found to be significantly high in group 1 which lost significance after Bonferroni correction. Patients with moderate symptoms had a significantly high frequency of IL-10 GCC/GCC genotype that did not remain significant after correction. These data from our small group of patients demonstrated that the only significant difference between the whole patient group and the controls was for TGF-? TT/GC genotype with a higher frequency in the patients. Due to the involvement of many other genes relating to the activity of Th1 cytokines, further studies are required to determine the molecular basis of the susceptibility to psoriasis.

🔖

Bu Makaleye Atıf Yap

TEMURHAN, S., OĞUZ, F. S., PİRMİT, S., KARAHAN, G. E., KEKİK, Ç. Ç., ONSUN, N. (2022). Psoriasis vulgarisli hastalarda sitokin gen polimorfizminin araştırılması. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 50 - Sayı: 1, 34–38. https://ajindex.com/articles/621746

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

Abanmi A, Al Harthi F, Al Agla R, Khan HA, Tariq M: Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia. Int J Dermatol 2005;44:82-3.
Baran W, Szepietowski JC, Mazur G, Baran E: IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm Venereol 2008;88:113-6.
Farber EM, Bright RD, Nall ML: Psoriasis. A questionnaire survey of 2,144 patients. Arch Dermatol 1968;98:248-59.
Reich K, Mössner R, Konig IR, Westphal G, Ziegler A, Neumann C: Promoter polymorphisms of the genes encoding tumor necrosis factor- alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol 2002;118:155-63.
Krueger G, Ellis CN: Psoriasis--recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 2005;53(Suppl 1):94-100.
Chang YT, Chou CT, Yu CW, et al: Cytokine gene polymorphisms in Chinese patients with psoriasis. Br J Dermatol 2007;156:899-905.
Reich K, Westphal G, Schulz T, et al: Combined analysis of polymorphisms of the tumor necrosis factor-? and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999;113:214-20.
Höhler T, Kruger A, Schneider PM, et al: A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997;109:562-5.
Baran W, Szepietowski JC, Mazur G, Baran E: A-308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients. Acta Dermatovenerol Alp Panonica Adriat 2006;15:113-8.
Baran W, Szepietowski JC, Mazur G, Baran E: TGF-beta(1) gene polymorphism in psoriasis vulgaris. Cytokine 2007;38:8-11.
Kingo K, Fredriksson T, Petterson U: Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
Bowcock AM, Barker JN: Genetics of psoriasis: the potential impact on new therapies. J Am Acad Dermatol 2003;49(Suppl 2):51-6.
Gustincich S, Manfiolett G, Del Sal G, Schneider C, Carninci P: A fast method for high-quality genomic DNA extraction from whole human blood. Bio Techniques 1991;11:298-300.
Olerup O, Zetterquist H: DR low resolution PCR-SSP typing-a correction and an up-date. Tissue Antigens 1993;41:55-6.
Balding J, Kane D, Livingstone W, et al: Cytokine gene polymorphisms: Association with psoriatic arthritis susceptibility and severity. Arthritis